retatrutide clinical trials status 2025 HAS NOT BEEN APPROVED YET & CURRENTLY IN PHASE III TRIALS⛔️ Retatrutide is not currently FDA-approved, as it is in Phase III clinical with anticipated completion in 2025–2026 and retatrutide clinical trial results weight

The complaint alleges several instances when Fella Healths non-physician personnel advised patients on medication doses and side effects and implied that they could adjust patient prescriptions, without mentioning the need for medical input

Diarrhea Loose stools may occur in some patients, especially in early weeks

Hyaluronic acid Although not a collagen precursor, oral hyaluronic acid has been studied for its potential to support skin hydration and elasticity and is frequently combined with collagen ingredients

2.5mg is a therapeutic dose capable of producing meaningful weight loss, not a placebo starter

However, their benefits are typically sustained only while the medication is actively used